A large-scale international collaborative study lead by Professor Jacques Simard from Université Laval and Professor Douglas Easton at the University of Cambridge, UK, has identified new genes associated with breast cancer that could eventually be included in tests to identify women at increased risk.
Deerfield gives up rights to Windtree therapy; Travere inks deal with Renalys in Asia; Celularity raises $21M
Plus, news about Prime Medicine, Sagimet Biosciences and Adicet Bio: Deerfield terminates rights to 2017 deal with Windtree Therapeutics: The biotech last year in-licensed Aerosurf,